Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.66% | -21.15% | 10.18% | 35.99% | 30.08% |
| Total Depreciation and Amortization | -26.67% | -25.00% | -79.69% | -78.79% | -77.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 84.97% | 61.28% | 22.56% | -25.90% | 30.38% |
| Change in Net Operating Assets | -107.01% | 738.83% | 748.16% | 158.50% | 183.52% |
| Cash from Operations | -102.72% | 69.44% | 72.34% | 82.01% | 63.69% |
| Capital Expenditure | 2.29% | 6.02% | 13.82% | 18.54% | -29.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.29% | 6.02% | 9.61% | 14.82% | -39.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 216.94% | -58.96% | -58.96% | -79.19% | -79.27% |
| Repurchase of Common Stock | 65.85% | 65.85% | -123.46% | -123.46% | -290.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,867.98% | 317.48% | 133.70% | 76.41% | 79.35% |
| Cash from Financing | 313.56% | -44.52% | -55.66% | -80.29% | -80.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 190.42% | 683.65% | 101.76% | 4.15% | -223.20% |